This is a preview of subscription content, log in via an institution to check access.
Reference
Rubio-Valera M, et al. Cost-effectiveness of antidepressants versus active monitoring for mild-to-moderate major depressive disorder: a multisite non-randomized-controlled trial in primary care (INFAP study). European Journal of Health Economics : 6 Feb 2019. Available from: URL: https://doi.org/10.1007/s10198-019-01034-5
Rights and permissions
About this article
Cite this article
Is active monitoring a cost-effective option in depression?. PharmacoEcon Outcomes News 822, 20 (2019). https://doi.org/10.1007/s40274-019-5672-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-019-5672-5